Having trouble accessing articles? Reset your cache.

STA-9090: Phase I started

Synta began an open-label, dose-escalation Phase

Read the full 68 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE